Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Medtronic
Healthtrust
Chubb
Mallinckrodt
US Army
Harvard Business School
Johnson and Johnson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLARGINE; LIXISENATIDE

« Back to Dashboard

INSULIN GLARGINE; LIXISENATIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi-aventis Us SOLIQUA 100/33 insulin glargine; lixisenatide SOLUTION;SUBCUTANEOUS 208673 NDA Sanofi-Aventis U.S. LLC N 0024-5761-05
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cerilliant
Moodys
Covington
Federal Trade Commission
Chubb
Boehringer Ingelheim
Teva
Dow